ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 16th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • Delaware
This Asset Purchase Agreement (this “Agreement”) is made and entered into as of the 7th day of May 2018 (the “Closing Date”), by and between
CONFIDENTIAL TREATMENT REQUESTED: Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (“[*****]”) to denote where omissions have been made. The...Development Services Agreement • May 16th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations
The State of the Netherlands, represented by the Minister of Public Health, Welfare and Sports, on behalf of the Minister, Projectdirectie ALT, The Institute for Translational Vaccinology (Intravacc), having its offices at Antonie van Leeuwenhoeklaan 9, 3721 MA Bilthoven, The Netherlands, legally represented by its General Director [****], hereinafter referred to as “Intravacc”;
LICENSE AGREEMENT BY AND BETWEEN MACROGENICS, INC. AND PROVENTION BIO, INC.License Agreement • May 16th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • Delaware
This LICENSE AGREEMENT (this “Agreement”) is entered into as of May 7, 2018 (the “Effective Date”), by and between PROVENTION BIO, INC., a Delaware corporation, having its principal place of business at (“Provention”) and MACROGENICS, INC., a Delaware corporation having its principal place of business at 9704 Medical Center Drive, Rockville, MD 20850 (hereinafter “MacroGenics”). Provention and MacroGenics are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
